438 related articles for article (PubMed ID: 22700549)
1. Porin alterations present in non-carbapenemase-producing Enterobacteriaceae with high and intermediate levels of carbapenem resistance in Chile.
Wozniak A; Villagra NA; Undabarrena A; Gallardo N; Keller N; Moraga M; Román JC; Mora GC; García P
J Med Microbiol; 2012 Sep; 61(Pt 9):1270-1279. PubMed ID: 22700549
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic and molecular characteristics of carbapenem-non-susceptible Enterobacteriaceae from a teaching hospital in Wenzhou, southern China.
Zhou T; Zhang X; Guo M; Ye J; Lu Y; Bao Q; Chi W
Jpn J Infect Dis; 2013; 66(2):96-102. PubMed ID: 23514904
[TBL] [Abstract][Full Text] [Related]
3. Distribution of extended-spectrum β-lactamases, AmpC β-lactamases, and carbapenemases among Enterobacteriaceae isolates causing intra-abdominal infections in the Asia-Pacific region: results of the study for Monitoring Antimicrobial Resistance Trends (SMART).
Sheng WH; Badal RE; Hsueh PR;
Antimicrob Agents Chemother; 2013 Jul; 57(7):2981-8. PubMed ID: 23587958
[TBL] [Abstract][Full Text] [Related]
4. Role of association of OmpK35 and OmpK36 alteration and bla
Hamzaoui Z; Ocampo-Sosa A; Fernandez Martinez M; Landolsi S; Ferjani S; Maamar E; Saidani M; Slim A; Martinez-Martinez L; Boutiba-Ben Boubaker I
Int J Antimicrob Agents; 2018 Dec; 52(6):898-905. PubMed ID: 29621592
[TBL] [Abstract][Full Text] [Related]
5. Comparative activities of doripenem versus isolates, mutants, and transconjugants of Enterobacteriaceae and Acinetobacter spp. with characterized beta-lactamases.
Mushtaq S; Ge Y; Livermore DM
Antimicrob Agents Chemother; 2004 Apr; 48(4):1313-9. PubMed ID: 15047535
[TBL] [Abstract][Full Text] [Related]
6. Assessment of extended-spectrum β-lactamase, KPC carbapenemase and porin resistance mechanisms in clinical samples of Klebsiella pneumoniae and Enterobacter spp.
Jaskulski MR; Medeiros BC; Borges JV; Zalewsky R; Fonseca ME; Marinowic DR; Rocha MP; Nodari P; Machado DC
Int J Antimicrob Agents; 2013 Jul; 42(1):76-9. PubMed ID: 23664677
[TBL] [Abstract][Full Text] [Related]
7. What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline.
Livermore DM; Warner M; Mushtaq S; Doumith M; Zhang J; Woodford N
Int J Antimicrob Agents; 2011 May; 37(5):415-9. PubMed ID: 21429716
[TBL] [Abstract][Full Text] [Related]
8. Characterization of carbapenem-resistant Escherichia coli and Klebsiella pneumoniae from a healthcare region in Hong Kong.
Ho PL; Cheung YY; Wang Y; Lo WU; Lai EL; Chow KH; Cheng VC
Eur J Clin Microbiol Infect Dis; 2016 Mar; 35(3):379-85. PubMed ID: 26740321
[TBL] [Abstract][Full Text] [Related]
9. Spread of an OmpK36-modified ST15 Klebsiella pneumoniae variant during an outbreak involving multiple carbapenem-resistant Enterobacteriaceae species and clones.
Novais A; Rodrigues C; Branquinho R; Antunes P; Grosso F; Boaventura L; Ribeiro G; Peixe L
Eur J Clin Microbiol Infect Dis; 2012 Nov; 31(11):3057-63. PubMed ID: 22706513
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of ertapenem resistance in Enterobacteriaceae isolates in a tertiary university hospital.
Chung HS; Yong D; Lee M
J Investig Med; 2016 Jun; 64(5):1042-9. PubMed ID: 27101841
[TBL] [Abstract][Full Text] [Related]
11. Activity of ceftazidime-avibactam against multidrug-resistance Enterobacteriaceae expressing combined mechanisms of resistance.
López-Hernández I; Alonso N; Fernández-Martínez M; Zamorano L; Rivera A; Oliver A; Conejo MC; Martínez-Martínez L; Navarro F; Pascual A
Enferm Infecc Microbiol Clin; 2017 Oct; 35(8):499-504. PubMed ID: 27887765
[TBL] [Abstract][Full Text] [Related]
12. [Carbapenem resistance in ESBL positive Enterobacteriaceae isolates causing invasive infections].
Eser OK; Altun Uludağ H; Ergin A; Boral B; Sener B; Hasçelik G
Mikrobiyol Bul; 2014 Jan; 48(1):59-69. PubMed ID: 24506716
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal survey of carbapenem resistance and resistance mechanisms in Enterobacteriaceae and non-fermenters from the USA in 2007-09.
Davies TA; Marie Queenan A; Morrow BJ; Shang W; Amsler K; He W; Lynch AS; Pillar C; Flamm RK
J Antimicrob Chemother; 2011 Oct; 66(10):2298-307. PubMed ID: 21775338
[TBL] [Abstract][Full Text] [Related]
14. Genotypic characterization and in vitro activities of tigecycline and polymyxin B for members of the Enterobacteriaceae with decreased susceptibility to carbapenems.
Zhang R; Cai JC; Zhou HW; Nasu M; Chen GX
J Med Microbiol; 2011 Dec; 60(Pt 12):1813-1819. PubMed ID: 21835972
[TBL] [Abstract][Full Text] [Related]
15. Emergence of carbapenem-resistant OXA-48 carbapenemase-producing Enterobacteriaceae in Tunisia.
Saïdani M; Hammami S; Kammoun A; Slim A; Boutiba-Ben Boubaker I
J Med Microbiol; 2012 Dec; 61(Pt 12):1746-1749. PubMed ID: 22918869
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of meropenem/vaborbactam and characterisation of carbapenem resistance mechanisms among carbapenem-resistant Enterobacteriaceae from the 2015 meropenem/vaborbactam surveillance programme.
Pfaller MA; Huband MD; Mendes RE; Flamm RK; Castanheira M
Int J Antimicrob Agents; 2018 Aug; 52(2):144-150. PubMed ID: 29510189
[TBL] [Abstract][Full Text] [Related]
17. Successful containment of carbapenem-resistant Enterobacteriaceae by strict contact precautions without active surveillance.
Kim NH; Han WD; Song KH; Seo HK; Shin MJ; Kim TS; Park KU; Ahn S; Yoo JS; Kim ES; Kim HB
Am J Infect Control; 2014 Dec; 42(12):1270-3. PubMed ID: 25465255
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic screening of carbapenemases and associated β-lactamases in carbapenem-resistant Enterobacteriaceae.
Birgy A; Bidet P; Genel N; Doit C; Decré D; Arlet G; Bingen E
J Clin Microbiol; 2012 Apr; 50(4):1295-302. PubMed ID: 22259214
[TBL] [Abstract][Full Text] [Related]
19. Characterization of carbapenemases, extended spectrum β-lactamases and molecular epidemiology of carbapenem-non-susceptible Enterobacter cloacae in a Chinese hospital in Chongqing.
Dai W; Sun S; Yang P; Huang S; Zhang X; Zhang L
Infect Genet Evol; 2013 Mar; 14():1-7. PubMed ID: 23220359
[TBL] [Abstract][Full Text] [Related]
20. [Investigation of the susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems].
Kuzucu C; Yetkin F; Görgeç S; Ersoy Y
Mikrobiyol Bul; 2011 Jan; 45(1):28-35. PubMed ID: 21341156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
